Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

Impella RP® Support for Univentricular Shock

Navin Kapur, MD, uses Impella RP to effectively manage univentricular shock in a patient with right ventricular failure.

Large Bore Femoral and Axillary Closure with Amir Kaki, MD

Amir Kaki, MD, discusses large bore femoral and axillary closure techniques as well as vascular closure devices currently on the market and in the pipeline. 

Alternative Access Sites for Large Bore Procedures with Rajiv Tayal, MD

Rajiv Tayal, MD, discusses axillary access techniques for large bore procedures as well as other alternative access skills for advanced interventional operators.

Assessing Impella® Heart Pump Position with Echocardiography

Echocardiography for assessing Impella position—a discussion with Clinical Support Specialist Michael Galvin, RDCS.

Right Heart Failure and the Impella RP® with SmartAssist® Heart Pump

This FAQ discusses the causes, incidence, and diagnosis of right heart failure and how the Impella RP with SmartAssist heart pump can support the right side of the heart.

What is the STEMI DTU™ Pivotal Trial?  

The STEMI DTU pivotal trial is a prospective, multicenter, two-arm randomized controlled trial that plans to enroll 668 patients undergoing treatment for a STEMI heart attack. 

Impella® Management in the CCU: Inotrope Weaning, Repositioning, Invasive Monitoring, Impella Heart Pumps and ECMO

Three intensivists discuss managing Impella patients in the CCU, focusing on weaning off inotropes, repositioning Impella, invasive monitoring, and use of Impella and ECMO.

Roma Verona Study: Complete Revascularization Associated with Significant Improvement in LVEF and Long-Term Survival

Francesco Burzotta, MD, and Carlo Trani, MD, discuss the long-term outcome of the extent of revascularization in complex, high-risk patients indicated for Protected PCI.

Instituting a Cardiogenic Shock Protocol to Improve Outcomes

Alexander Truesdell, MD, and Behnam Tehrani, MD, discuss improved outcomes after implementing a cardiogenic shock protocol at Inova Heart and Vascular Institute. 

What is the purpose of the STEMI DTU™ RCT?

This FAQ provides key information about the purpose and design of the STEMI DTU pivotal randomized controlled trial and how to participate.

FAQ: What Is the Clinical Evidence That Supports the Benefit of Placing the Impella® Heart Pump Pre-PCI?

A preponderance of evidence from the FDA cVAD Study, Impella Quality Database and the physician-initiated NSCI study supports the recommendation that placing Impella 2.5® or Impella CP® pre-PCI improves outcomes.

Data from the NCSI Study Demonstrates 72% Survival with 98% Native Heart Recovery

William O'Neill, MD, discusses data from the National Cardiogenic Shock Initiative (NCSI) study presented at the 2019 SCAI Scientific Sessions.

High-Risk PCI with Impella® Support and Atherectomy

Thom Dahle, MD, presents a high-risk PCI case managed with a heart team approach that entails Impella support and atherectomy.

Quick Tips on Access and Closure

Alex Truesdell, MD, shares his top tips for safe vascular access and closure.

Protected PCI with Impella® and Intravascular Lithotripsy with Shockwave

Robert Riley, MD, presents a high-risk PCI case requiring hemodynamic support with the Impella CP® heart pump and intravascular lithotripsy with Shockwave for vascular access.

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].